$VTGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VistaGen Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in VistaGen Therapeutics, Inc.. Get notifications about new insider transactions in VistaGen Therapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 04 2021 | VTGN | VistaGen Therapeut ... | Cunningham Ann Michelle | CHIEF COMMERCIAL OF ... | Option Exercise | A | 2.53 | 300,000 | 759,000 | 300,000 | |
| Apr 27 2021 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | M | 1.50 | 5,000 | 7,500 | 0 | |
| Apr 27 2021 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Buy | M | 1.50 | 5,000 | 7,500 | 40,375 | 35.4 K to 40.4 K (+14.13 %) |
| Apr 27 2021 | VTGN | VistaGen Therapeut ... | Curley Joanne | Option Exercise | A | 2.04 | 75,000 | 153,000 | 75,000 | ||
| Mar 22 2021 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | M | 1.50 | 2,500 | 3,750 | 0 | ||
| Mar 22 2021 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Buy | M | 1.50 | 2,500 | 3,750 | 2,500 | 0 to 2.5 K | |
| Mar 22 2021 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | M | 1.50 | 2,500 | 3,750 | 0 | ||
| Mar 22 2021 | VTGN | VistaGen Therapeut ... | SAXE JON S | Buy | M | 1.50 | 2,500 | 3,750 | 5,751 | 3.3 K to 5.8 K (+76.90 %) | |
| Feb 02 2021 | VTGN | VistaGen Therapeut ... | Ginski Mark J | SENIOR VP, HEAD OF ... | Option Exercise | A | 2.14 | 200,000 | 428,000 | 200,000 | |
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | Cunningham Ann Michelle | Option Exercise | A | 1.77 | 75,000 | 132,750 | 75,000 | ||
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.77 | 300,000 | 531,000 | 300,000 | |
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Grant | A | 0.45 | 5,000 | 2,261 | 35,375 | 30.4 K to 35.4 K (+16.46 %) |
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | A | 1.77 | 150,000 | 265,500 | 150,000 | |
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Grant | A | 0.45 | 5,000 | 2,261 | 10,000 | 5 K to 10 K (+100.00 %) |
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | Smith Mark Alan | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 1.77 | 150,000 | 265,500 | 150,000 | |
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | Smith Mark Alan | CHIEF MEDICAL OFFIC ... | Grant | A | 0.45 | 5,000 | 2,261 | 10,000 | 5 K to 10 K (+100.00 %) |
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.77 | 75,000 | 132,750 | 75,000 | ||
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | A | 1.77 | 75,000 | 132,750 | 75,000 | ||
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.77 | 75,000 | 132,750 | 75,000 | ||
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | MCPARTLAND MARK A. | VP CORPORATE DEVELO ... | Option Exercise | A | 1.77 | 150,000 | 265,500 | 150,000 | |
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | A | 1.77 | 75,000 | 132,750 | 75,000 | ||
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | MCPARTLAND MARK A. | VP CORPORATE DEVELO ... | Option Exercise | A | 1.77 | 150,000 | 265,500 | 150,000 | |
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.77 | 150,000 | 265,500 | 150,000 | |
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Grant | A | 0.45 | 5,000 | 2,261 | 87,724 | 82.7 K to 87.7 K (+6.04 %) |
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | A | 1.77 | 75,000 | 132,750 | 75,000 | ||
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.77 | 150,000 | 265,500 | 150,000 | |
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Grant | A | 0.45 | 5,000 | 2,261 | 87,724 | 82.7 K to 87.7 K (+6.04 %) |
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | A | 1.77 | 75,000 | 132,750 | 75,000 | ||
| Aug 24 2020 | VTGN | VistaGen Therapeut ... | SAXE JON S | Buy | P | 0.69 | 30,000 | 20,700 | 50,000 | 20 K to 50 K (+150.00 %) | |
| Jul 01 2020 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Grant | A | 0.45 | 5,000 | 2,240 | 67,724 | 62.7 K to 67.7 K (+7.97 %) |
| Jul 01 2020 | VTGN | VistaGen Therapeut ... | Smith Mark Alan | CHIEF MEDICAL OFFIC ... | Grant | A | 0.45 | 5,000 | 2,240 | 5,000 | 0 to 5 K |
| Jul 01 2020 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Grant | A | 0.45 | 5,000 | 2,240 | 5,000 | 0 to 5 K |
| Jul 01 2020 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Grant | A | 0.45 | 5,000 | 2,240 | 30,375 | 25.4 K to 30.4 K (+19.70 %) |
| Apr 27 2020 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | A | 0.40 | 75,000 | 29,850 | 75,000 | ||
| Apr 27 2020 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | A | 0.40 | 75,000 | 29,850 | 75,000 | ||
| Apr 27 2020 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 0.40 | 75,000 | 29,850 | 75,000 | ||
| Apr 27 2020 | VTGN | VistaGen Therapeut ... | MCPARTLAND MARK A. | VP CORPORATE DEVELO ... | Option Exercise | A | 0.40 | 150,000 | 59,700 | 150,000 | |
| Apr 27 2020 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | A | 0.40 | 150,000 | 59,700 | 150,000 | |
| Apr 27 2020 | VTGN | VistaGen Therapeut ... | Smith Mark Alan | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 0.40 | 150,000 | 59,700 | 150,000 | |
| Apr 27 2020 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 0.40 | 150,000 | 59,700 | 150,000 | |
| Apr 27 2020 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.40 | 300,000 | 119,400 | 300,000 | |
| Apr 27 2020 | VTGN | VistaGen Therapeut ... | Cunningham Ann Michelle | Option Exercise | A | 0.40 | 75,000 | 29,850 | 75,000 | ||
| Nov 21 2019 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Buy | P | 0.34 | 15,000 | 5,100 | 15,000 | 0 to 15 K |
| Oct 22 2019 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | A | 1.41 | 150,000 | 211,500 | 150,000 | |
| Oct 22 2019 | VTGN | VistaGen Therapeut ... | MCPARTLAND MARK A. | VP CORPORATE DEVELO ... | Option Exercise | A | 1.41 | 100,000 | 141,000 | 100,000 | |
| Oct 22 2019 | VTGN | VistaGen Therapeut ... | Smith Mark Alan | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 1.41 | 100,000 | 141,000 | 100,000 | |
| Oct 22 2019 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.41 | 175,000 | 246,750 | 175,000 | |
| Oct 22 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.41 | 300,000 | 423,000 | 300,000 | |
| Oct 22 2019 | VTGN | VistaGen Therapeut ... | Cunningham Ann Michelle | Option Exercise | A | 1.41 | 75,000 | 105,750 | 75,000 | ||
| Oct 22 2019 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | A | 1.41 | 75,000 | 105,750 | 75,000 | ||
| Oct 22 2019 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | A | 1.41 | 75,000 | 105,750 | 75,000 | ||
| Oct 22 2019 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.41 | 75,000 | 105,750 | 75,000 | ||
| May 28 2019 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.00 | 50,000 | 50,000 | 50,000 | ||
| May 28 2019 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | A | 1.00 | 50,000 | 50,000 | 50,000 | ||
| May 28 2019 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | A | 1.00 | 50,000 | 50,000 | 50,000 | ||
| May 28 2019 | VTGN | VistaGen Therapeut ... | Cunningham Ann Michelle | Option Exercise | A | 1.00 | 50,000 | 50,000 | 50,000 | ||
| May 28 2019 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.00 | 150,000 | 150,000 | 150,000 | |
| May 28 2019 | VTGN | VistaGen Therapeut ... | Smith Mark Alan | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 1.00 | 150,000 | 150,000 | 150,000 | |
| May 28 2019 | VTGN | VistaGen Therapeut ... | MCPARTLAND MARK A. | VP CORPORATE DEVELO ... | Option Exercise | A | 1.00 | 150,000 | 150,000 | 150,000 | |
| May 28 2019 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | A | 1.00 | 150,000 | 150,000 | 150,000 | |
| May 28 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.00 | 170,000 | 170,000 | 170,000 | |
| May 28 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.00 | 80,000 | 80,000 | 80,000 | |
| Mar 14 2019 | VTGN | VistaGen Therapeut ... | SAXE JON S | Buy | P | 1.27 | 7,920 | 10,086 | 20,000 | 12.1 K to 20 K (+65.56 %) | |
| Mar 14 2019 | VTGN | VistaGen Therapeut ... | SAXE JON S | Buy | P | 1.26 | 12,080 | 15,201 | 12,080 | 0 to 12.1 K | |
| Mar 14 2019 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | M | 1.50 | 2,500 | 3,750 | 0 | |
| Mar 14 2019 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Buy | M | 1.50 | 2,500 | 3,750 | 62,724 | 60.2 K to 62.7 K (+4.15 %) |
| Jan 30 2019 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | M | 1.50 | 1,000 | 1,500 | 0 | ||
| Jan 30 2019 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | M | 1.50 | 375 | 563 | 0 | ||
| Jan 30 2019 | VTGN | VistaGen Therapeut ... | SAXE JON S | Buy | M | 1.50 | 1,000 | 1,500 | 3,251 | 2.3 K to 3.3 K (+44.42 %) | |
| Jan 30 2019 | VTGN | VistaGen Therapeut ... | SAXE JON S | Buy | M | 1.50 | 375 | 563 | 2,251 | 1.9 K to 2.3 K (+19.99 %) | |
| Jan 15 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | M | 1.50 | 3,000 | 4,500 | 0 | |
| Jan 15 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | M | 1.50 | 1,125 | 1,688 | 0 | |
| Jan 15 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | M | 1.50 | 21,250 | 31,875 | 0 | |
| Jan 15 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Buy | M | 1.50 | 3,000 | 4,500 | 25,375 | 22.4 K to 25.4 K (+13.41 %) |
| Jan 15 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Buy | M | 1.50 | 1,125 | 1,688 | 22,375 | 21.3 K to 22.4 K (+5.29 %) |
| Jan 15 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Buy | M | 1.50 | 21,250 | 31,875 | 21,250 | 0 to 21.3 K |
| Jan 14 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.70 | 220,000 | 374,000 | 220,000 | |
| Jan 14 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.70 | 220,000 | 374,000 | 220,000 | |
| Jan 14 2019 | VTGN | VistaGen Therapeut ... | Cunningham Ann Michelle | Option Exercise | A | 1.74 | 25,000 | 43,500 | 25,000 | ||
| Jan 14 2019 | VTGN | VistaGen Therapeut ... | Cunningham Ann Michelle | Option Exercise | A | 1.74 | 25,000 | 43,500 | 25,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 175,000 | 262,500 | 175,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 1.96 | 175,000 | 343,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 100,000 | 150,000 | 100,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 3.80 | 100,000 | 380,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 200,000 | 300,000 | 200,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 3.49 | 200,000 | 698,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 5,000 | 7,500 | 5,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 10.00 | 5,000 | 50,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 21,250 | 31,875 | 21,250 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 10.00 | 21,250 | 212,500 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 50,000 | 75,000 | 50,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 10.00 | 50,000 | 500,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 1,125 | 1,688 | 1,125 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 10.00 | 1,125 | 11,250 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 3,000 | 4,500 | 3,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 10.00 | 3,000 | 30,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.50 | 125,000 | 187,500 | 125,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 1.96 | 125,000 | 245,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.50 | 80,000 | 120,000 | 80,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 3.80 | 80,000 | 304,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.50 | 125,000 | 187,500 | 125,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 3.49 | 125,000 | 436,250 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.50 | 12,500 | 18,750 | 12,500 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 10.00 | 12,500 | 125,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.50 | 1,250 | 1,875 | 1,250 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 10.00 | 1,250 | 12,500 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.50 | 2,500 | 3,750 | 2,500 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 10.00 | 2,500 | 25,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.50 | 35,000 | 52,500 | 35,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | D | 1.96 | 35,000 | 68,600 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.50 | 25,000 | 37,500 | 25,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | D | 3.80 | 25,000 | 95,000 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.50 | 25,000 | 37,500 | 25,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | D | 3.49 | 25,000 | 87,250 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.50 | 2,500 | 3,750 | 2,500 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | D | 10.00 | 2,500 | 25,000 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.50 | 7,500 | 11,250 | 7,500 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | D | 10.00 | 7,500 | 75,000 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.50 | 1,000 | 1,500 | 1,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | D | 10.00 | 1,000 | 10,000 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.50 | 375 | 563 | 375 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | D | 10.00 | 375 | 3,750 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | A | 1.50 | 100,000 | 150,000 | 100,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | D | 1.96 | 100,000 | 196,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | A | 1.50 | 50,000 | 75,000 | 50,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | D | 3.80 | 50,000 | 190,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | A | 1.50 | 75,000 | 112,500 | 75,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | D | 3.49 | 75,000 | 261,750 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | A | 1.50 | 1,000 | 1,500 | 1,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | D | 8.00 | 1,000 | 8,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | A | 1.50 | 4,323 | 6,485 | 4,323 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | D | 10.00 | 4,323 | 43,230 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | A | 1.50 | 678 | 1,017 | 678 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | D | 10.00 | 678 | 6,780 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | A | 1.50 | 35,000 | 52,500 | 35,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | D | 1.96 | 35,000 | 68,600 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | A | 1.50 | 25,000 | 37,500 | 25,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | D | 3.80 | 25,000 | 95,000 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | A | 1.50 | 25,000 | 37,500 | 25,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | D | 3.49 | 25,000 | 87,250 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | A | 1.50 | 25,000 | 37,500 | 25,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | D | 8.00 | 25,000 | 200,000 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | MCPARTLAND MARK A. | VP CORPORATE DEVELO ... | Option Exercise | A | 1.50 | 100,000 | 150,000 | 250,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | MCPARTLAND MARK A. | VP CORPORATE DEVELO ... | Option Exercise | D | 1.96 | 100,000 | 196,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | MCPARTLAND MARK A. | VP CORPORATE DEVELO ... | Option Exercise | A | 1.50 | 40,000 | 60,000 | 40,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | MCPARTLAND MARK A. | VP CORPORATE DEVELO ... | Option Exercise | D | 3.80 | 40,000 | 152,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | MCPARTLAND MARK A. | VP CORPORATE DEVELO ... | Option Exercise | A | 1.50 | 125,000 | 187,500 | 125,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | MCPARTLAND MARK A. | VP CORPORATE DEVELO ... | Option Exercise | D | 4.27 | 125,000 | 533,750 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | A | 1.50 | 35,000 | 52,500 | 35,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | D | 1.96 | 35,000 | 68,600 | 0 |